Open Access. Powered by Scholars. Published by Universities.®
- Publication Type
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
Institute For Global Health And Development : Issue 5 - July 2023, Institute For Global Health And Development
Institute For Global Health And Development : Issue 5 - July 2023, Institute For Global Health And Development
IGHD Newsletter
• Research Highlights
• Key Publications
• IGHD in the News
• Webinars, Academics & Conferences
• ‘Choice’ Programme - Technical Advisory Group
• Welcome New Team Members
• Mark your Calendars: Upcoming Event
• Congratulations Team IGHD
• Collaborate With Us
Institute For Global Health And Development : Issue 4 - July - Sept 2022, Institute For Global Health And Development
Institute For Global Health And Development : Issue 4 - July - Sept 2022, Institute For Global Health And Development
IGHD Newsletter
• Research Highlights
• Key Publications
• News
• Reflections from IGHD’s Associate Faculty
• Reflections from IGHD’s Summer Interns
• Webinars and Dialogues
• Mark your Calendars: Upcoming Event
• Obituary
• Collaborate With Us
Tocilizumab And Covid-19: A Meta-Analysis Of 2120 Patients With Severe Disease And Implications For Clinical Trial Methodologies, Azza Sarfraz, Zouina Sarfraz, Muzna Sarfraz, Hinna Aftab, Zainab Pervaiz
Tocilizumab And Covid-19: A Meta-Analysis Of 2120 Patients With Severe Disease And Implications For Clinical Trial Methodologies, Azza Sarfraz, Zouina Sarfraz, Muzna Sarfraz, Hinna Aftab, Zainab Pervaiz
Department of Paediatrics and Child Health
Background/aim: Since the outbreak of the COVID-19, numerous therapies to counteract this severe disease have emerged. The benefits of Tocilizumab for severely infected COVID-19 patients and the methodologies of ongoing clinical trials are explored.
Materials and methods: A systematic search adhering to PRISMA guidelines was conducted in PubMed, Cochrane Central, medRxiv, and bioRxiv using the following keywords: “Tocilizumab,” “Actemra,” “COVID-19.” An additional subsearch was conducted on Clinicaltrials.gov to locate ongoing tocilizumab trials.
Results: A total of 13 studies were included in the meta-analysis comprising 2120 patients. The treatment group had lower mortality compared to the control group (OR = 0.42, …